Auszug
Unter Behandlung mit manchen Medikamenten Kann eine Gewichtszunahme auft reten, die den Nutzen dieser Substanzen erheblich schmälert. Probleme, die aus dieser unerwünschten Arzneimittelwirkung resultieren, bestehen in Minderung der Lebensqualität, Stigmatisierung und erhöhtem Risiko für adipositasassoziierte Erkrankungen. Nachlassende Zuverlässigkeit bei der Einnahme oder vorzeitiges Beenden der behandlung sind mögliche Folgen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Allison DB, Mackell JA, McDonnell DD (2003) The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr Services 54: 565–567
Allison DB, Mentore JL, Heo M et al (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156: 1686–1696
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27: 596–601
Fenton WS, Chavez MR (2006) Medication-induced weight gain and dyslipidemia in patients with schizophrenia. Am J Psychiatry 163: 1697–1704
Jallon P, Picard F (2001) Bodyweight gain and anticonvulsants: a comparative review. Drug Safety 24: 969–978
Malone M (2005) Medications associated with weight gain. Ann Pharmacother 39: 2046–2055
Paykel ES, Mueller PS, De la Vergne PM (1973) Amitriptyline, weight gain and carbohydrate craving: a side effect. Br J Psychiatry 123: 501–507
Pijl H, Meinders AE (1996) Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Safety 14: 329–342
Ryan MC, Collins P, Thakore JH (2003) Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 160: 284–289
Sansone RA, Sansone LA, Gaither GA, Morris JL (2004) Patient attitudes toward weight gain with medications. Gen Hosp Psychiatry 26: 487–489
Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmacher T (2003) Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 37: 193–220
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Lederbogen, F. (2008). Medikamentös induzierte Adipositas. In: Herpertz, S., de Zwaan, M., Zipfel, S. (eds) Handbuch Essstörungen und Adipositas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76882-1_45
Download citation
DOI: https://doi.org/10.1007/978-3-540-76882-1_45
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-76881-4
Online ISBN: 978-3-540-76882-1
eBook Packages: Medicine (German Language)